Financial Performance - The company's revenue for Q3 2022 reached ¥496,533,217.75, representing a 21.08% increase compared to the same period last year[5] - Net profit attributable to shareholders for Q3 2022 was ¥58,432,575.30, a significant increase of 106.86% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥53,554,323.42, up 148.16% from the previous year[5] - Basic earnings per share for Q3 2022 were ¥0.11, reflecting a 120.00% increase compared to the same period last year[5] - Total operating revenue for the current period reached ¥1,243,354,932.90, an increase of 12.5% compared to ¥1,105,083,748.49 in the previous period[27] - Net profit for the current period was ¥101,936,358.39, representing a 1.9% increase from ¥99,969,154.95 in the same period last year[28] - Basic earnings per share increased to ¥0.16 from ¥0.15, reflecting a growth of 6.7%[29] Assets and Liabilities - Total assets at the end of Q3 2022 amounted to ¥2,286,993,894.78, an increase of 7.23% from the end of the previous year[5] - Shareholders' equity attributable to the parent company was ¥1,241,036,284.81, up 3.21% from the end of the previous year[5] - The company's total liabilities reached CNY 1,013,222,649.49, up from CNY 880,632,931.34, marking an increase of about 15%[26] - The total current liabilities rose to CNY 875,629,787.55, compared to CNY 753,985,852.40 at the beginning of the year, indicating an increase of about 16%[25] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥59,463,340.16, showing a decrease of 52.26% compared to the same period last year[5] - Cash flow from financing activities increased significantly by 124.36% to ¥10,171,466.80, driven by a net inflow of borrowings compared to the previous year[11] - The net cash flow from investment activities was -43,138,518.25, compared to -92,964,254.00 in the previous year, indicating an improvement[31] - The cash and cash equivalents at the end of the period amounted to 299,528,280.69, compared to 152,213,147.56 at the end of the previous year[31] Expenses and Costs - Total operating costs amounted to ¥1,126,946,208.17, up 13.1% from ¥996,462,312.81 in the prior period[27] - R&D expenses rose by 28.32% to CNY 45.23 million as the company enhanced its product development efforts[10] - The company reported a tax expense of ¥15,655,728.14, slightly higher than ¥15,240,112.02 in the previous period[28] - The company reported a 245.73% increase in taxes and surcharges, mainly due to increased urban construction tax and property tax provisions[10] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 25,447, with the largest shareholder, Qu Jianguo, holding 33.72% of the shares[12] - Qu Jianguo, the controlling shareholder, has committed to relinquishing voting rights for 54,331,600 shares, representing 9.4134% of the total share capital[15] - The controlling shareholder, Mr. Qu Jianguo, donated 26 million shares, reducing his ownership from 38.90% to 34.32%, while the recipient foundation's ownership increased from 1.22% to 5.80%[19] Investments and Acquisitions - The company invested CNY 10.1 million in Yuan Energy Bio, increasing its shareholding from 6.57% to 11.82% after the capital increase[21] - The company has filed a civil lawsuit seeking CNY 20 million in damages related to an investment in the Houyu Fund, which remains unrecovered[22] - The company plans to further assess impairment losses related to its investment in the Houyu Fund based on ongoing communications with the fund manager[21] Other Comprehensive Income - Other comprehensive income increased by 585.63% primarily due to exchange rate changes and foreign currency translation[9] - Other comprehensive income after tax amounted to ¥13,358,792.41, compared to a loss of ¥739,499.56 in the previous period[28]

Financial Performance - The company's revenue for the reporting period was ¥746,821,715.15, representing a 7.46% increase compared to ¥694,997,397.16 in the same period last year [28]. - The net profit attributable to shareholders decreased by 45.12% to ¥31,186,812.70 from ¥56,829,677.26 year-on-year [28]. - The net cash flow from operating activities dropped significantly by 90.91% to ¥7,098,308.05, down from ¥78,073,653.46 in the previous year [28]. - The total assets at the end of the reporting period were ¥2,158,923,494.89, a 1.22% increase from ¥2,132,858,918.73 at the end of the previous year [28]. - The net assets attributable to shareholders decreased by 2.01% to ¥1,178,307,583.97 from ¥1,202,418,915.04 at the end of the previous year [28]. - The company's revenue increased by 7.46% year-on-year, while net profit attributable to shareholders decreased by 45.12% due to increased export shipping costs and labor expenses [49]. - Operating costs increased by 20.11% to ¥489.11 million from ¥407.21 million, primarily due to the reclassification of transportation costs as operating expenses [57]. - Research and development expenses rose by 23.01% to ¥26.85 million, attributed to increased employee bonuses and salaries [57]. - The company's cash and cash equivalents decreased by 373.65% to ¥-50.97 million from ¥18.63 million, reflecting a significant drop in cash flow from operating, investing, and financing activities [57]. - The company's net profit attributable to shareholders decreased by 45.12% to ¥31.19 million from ¥56.83 million, impacted by increased labor costs [57]. Market Expansion and Strategy - The company plans to expand its overseas sales channels while maintaining its market share in Europe and the United States, indicating significant growth potential in other regions [4]. - The company continues to focus on the development and manufacturing of water treatment products, including whole-house water purification systems and commercial drinking water purification machines [36]. - The company has expanded its product offerings to include over 1,700 varieties across 83 series, exporting to more than 100 countries and regions [39]. - The marketing strategy has been refined to focus on core advantages and target different customer segments effectively [40]. - The company aims to meet the growing consumer demand for comprehensive water treatment solutions as awareness of water quality improves [38]. - The company aims to expand its unique DSR marketing model to more cities in China, starting from Shanghai as a pilot market [54]. - The company plans to expand its market presence in the water treatment industry while leveraging its existing advantages in Shanghai and the East China region [99]. - The company plans to focus on expanding its market presence and investing in new technologies to drive future growth [194]. - The company is exploring potential mergers and acquisitions to strengthen its market position and diversify its product offerings [197]. Innovation and Development - The company has a strong emphasis on innovation, holding a total of 328 authorized patents, including 37 invention patents [55]. - The company is actively involved in the formulation of national standards for water efficiency, enhancing its role in the industry [37]. - The company has been recognized as a national high-tech enterprise since 2008 and has received various awards for its innovative products [47]. - The company has developed a series of skincare products utilizing advanced clinical-grade bioproducts, with core products passing regulatory approvals and demonstrating effective skin repair capabilities [98]. - The company has filed over 365 domestic and international patents, with 273 patents granted, showcasing its commitment to innovation [90]. - Ori-C101, a CAR-T product targeting advanced liver cancer, has shown a 44% objective response rate and a 78% disease control rate in clinical trials [92]. - The company has initiated exploratory clinical studies for over 10 innovative cell products, with promising safety and efficacy data [92]. - The company has allocated 4.6 million for research and development of new technologies and products [199]. - Research and development expenses accounted for 12% of total revenue, reflecting the company's commitment to innovation [197]. Financial Management and Risks - The company has actively engaged in mergers and acquisitions to enhance its business and market presence, which may increase financial pressure and require improved financial management [6]. - The company faces risks from intense market competition, overseas market fluctuations, and foreign exchange rate changes, and is implementing strategies to mitigate these risks [102]. - The company faces rising operational costs due to increasing labor costs and raw material prices, prompting efforts to enhance production automation and supply chain management to control these costs [103]. - Recent acquisitions have introduced financial risks, including increased financial pressure and potential impairment of goodwill if acquired businesses do not meet performance expectations [104]. - The fair value changes of equity investments could negatively impact the company's operating performance, especially if the invested entities face operational difficulties [105]. - Participation in industrial funds aims to enhance the company's competitive edge, but these investments carry risks related to long investment cycles and market volatility [105]. Environmental and Social Responsibility - The company has implemented a comprehensive environmental management system and has not experienced any environmental pollution incidents to date [115]. - The company has established a water recycling system that meets the discharge standards of GB/T18921-2002, ensuring no production wastewater is generated [116]. - The company has committed to reducing carbon emissions but did not disclose specific measures or effects during the reporting period [116]. - The company has a plan in place for emergency monitoring in case of environmental incidents, including collaboration with external testing groups [115]. - The company has established a monitoring system for potential environmental incidents, including water and air pollution monitoring [115]. - The company has not faced any administrative penalties related to environmental issues during the reporting period [115]. Shareholder and Corporate Governance - The company will not distribute cash dividends or issue bonus shares during this reporting period [9]. - The actual controller of the company has made irrevocable commitments regarding voting rights and shareholding, including a commitment to hold at least 30% of shares [119]. - The company has not experienced any changes in its board of directors or senior management during the reporting period [109]. - The company has not reported any overdue or unrecovered amounts in its wealth management investments [78]. - The company has not engaged in any derivative investments during the reporting period [79]. - The company has not sold any significant assets during the reporting period [81]. - The company has not utilized any fundraising during the reporting period [76]. - The company has not undergone any changes in its controlling shareholder or actual controller during the reporting period [167]. - The company has not reported any changes in state-owned or foreign institutional holdings during this period [157].

Financial Performance - The company's operating revenue for 2021 was ¥1,511,487,428.56, representing a 27.97% increase compared to ¥1,181,121,636.37 in 2020[23]. - The net profit attributable to shareholders for 2021 was ¥104,859,883.20, a significant increase of 296.93% from ¥26,417,590.62 in 2020[23]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥63,339,903.42, up 6,930.19% from ¥900,970.21 in 2020[23]. - The net cash flow from operating activities increased by 33.00% to ¥186,767,653.57 in 2021, compared to ¥140,429,986.48 in 2020[23]. - The total assets at the end of 2021 were ¥2,132,858,918.73, reflecting a 17.29% increase from ¥1,818,405,772.85 at the end of 2020[23]. - The company reported a basic earnings per share of ¥0.18 for 2021, a 260.00% increase from ¥0.05 in 2020[23]. - The company reported a significant increase in undistributed profits, reaching CNY 373,976,278.48, which is 17.53% of total assets, up from 16.26% at the beginning of the year[89]. - The total distributable profit for the fiscal year 2021 is reported at CNY 266,221,910.19, with cash dividends accounting for 100% of the profit distribution[182]. Dividend Distribution - The company plans to distribute a cash dividend of 1.00 RMB per 10 shares (including tax) to all shareholders, based on a total of 567,171,929 shares[9]. - The total cash dividend for the fiscal year 2021 is proposed to be CNY 1.00 per 10 shares, amounting to CNY 56,717,192.90, with no stock dividends or capital reserve transfers planned[184]. - The company’s cash dividend policy complies with the company’s articles of association and shareholder resolutions[181]. - The company’s board of directors provided independent opinions on the profit distribution plan, ensuring the protection of minority shareholders' rights[181]. Market Expansion and Strategy - The company has expanded its overseas sales channels while maintaining a strong market share in Europe and the United States, indicating significant growth potential in existing markets[5]. - The company anticipates a shift in consumer demand towards whole-house water treatment systems, moving from high-end consumers to a broader audience[34]. - The company aims to expand its market presence through vertical supply chain integration and strategic partnerships, targeting both domestic and international markets[123]. - The company is actively involved in the development of water treatment products, focusing on improving the quality of water for human use, and has received various national certifications[33]. - The company is focusing on enhancing its online sales channel, with a target of increasing e-commerce sales by 30% in the upcoming year[155]. Research and Development - The company has invested 100 million RMB in research and development for innovative health technology solutions[155]. - The total research and development (R&D) expenditure for 2021 was approximately 54.59 million yuan, accounting for 3.61% of operating revenue, showing a slight increase from 3.56% in 2020[78]. - The company launched several new products in 2021, including a wall-mounted soft water machine and a highly integrated under-sink water purification system, aimed at enhancing market competitiveness[77]. - The company is developing a new soft water machine (CS4H-0824) aimed at expanding its market presence and increasing customer options[75]. Operational Efficiency - The company emphasizes improving production efficiency and cost reduction to mitigate the impact of foreign exchange fluctuations on international pricing[6]. - The company has a production capacity of over 90% for its core components and products, ensuring high-quality manufacturing and cost efficiency[48]. - The company is focusing on enhancing production efficiency and cost management to mitigate risks associated with rising operating costs due to increasing labor and material prices[131]. - The gross margin improved to 45%, up from 40% in the previous year, indicating better cost management and pricing strategies[156]. Corporate Governance - The company has maintained a governance structure that ensures clear responsibilities and effective supervision, complying with regulatory requirements[191]. - The company has established a robust investor relations management system, utilizing multiple communication channels to engage with investors[140]. - The company has not reported any significant deviations from the regulatory requirements for corporate governance as set by the China Securities Regulatory Commission[141]. - The company has implemented a long-term incentive plan for senior management, aligning shareholder interests with company performance[140]. Environmental Initiatives - The company has implemented a comprehensive water recycling system, achieving a reduction of 560,000 tons in wastewater discharge from 2013 to 2021[199]. - The company invested over 1 million yuan in the renovation of natural rivers, transforming polluted water bodies into clean rivers[200]. - The company promotes a green development philosophy, focusing on energy conservation and carbon reduction in its manufacturing processes[200]. - The company has built a 1 MW solar power station, generating over 1 million kWh of electricity annually, contributing to carbon emission reduction[200]. Challenges and Risks - Over half of the company's sales revenue comes from international markets, primarily denominated in USD, exposing it to foreign exchange risks[6]. - The company acknowledges the risk of intensified market competition in the water treatment equipment industry, necessitating the maintenance of competitive advantages[130]. - The company has faced challenges due to the pandemic, particularly in the Shanghai region, but expects a gradual recovery in the domestic consumer market[9]. - The company is committed to improving its talent acquisition strategy to address the shortage of specialized personnel necessary for its business expansion[131].

Financial Performance - The company's revenue for Q1 2022 was CNY 335,819,450.56, representing a 2.33% increase compared to CNY 328,165,726.15 in the same period last year[3]. - Net profit attributable to shareholders decreased by 37.12% to CNY 15,924,291.20 from CNY 25,325,231.55 year-on-year[3]. - Total operating revenue for the current period is $335.82 million, an increase from $328.17 million in the previous period, representing a growth of approximately 2.52%[27]. - Net profit for the current period is $19.77 million, down from $29.55 million in the previous period, reflecting a decrease of approximately 33.23%[28]. - Total comprehensive income for the current period is $20.08 million, down from $30.98 million, a decrease of about 35.14%[29]. - Basic and diluted earnings per share decreased to $0.0281 from $0.0443, a decline of approximately 36.43%[29]. Cash Flow and Investments - The net cash flow from operating activities was negative at CNY -2,808,939.15, a decline of 109.88% compared to CNY 28,443,512.37 in the previous year[3]. - Cash flow from operating activities showed a net outflow of $2.81 million, contrasting with a net inflow of $28.44 million in the previous period[32]. - The net cash flow from investing activities was CNY 27,806,818.85, a significant improvement compared to CNY -60,243,483.61 in the same period last year[8]. - The company reported a net cash inflow from investing activities of $27.81 million, compared to a net outflow of $60.24 million in the previous period[32]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,132,227,437.91, a slight decrease of 0.03% from CNY 2,132,858,918.73 at the end of the previous year[3]. - The company's total liabilities decreased to CNY 859,921,622.51 from CNY 880,632,931.34, a reduction of about 2.4%[25]. - The total current liabilities decreased to CNY 736,199,211.41 from CNY 753,985,852.40, reflecting a reduction of about 2.4%[24][25]. - The company's equity attributable to shareholders rose to CNY 1,218,676,256.77 from CNY 1,202,418,915.04, indicating an increase of approximately 1.4%[25]. Shareholder Information - The company had a total of 32,293 common shareholders at the end of the reporting period[10]. - The top 10 unrestricted shareholders hold a total of 104,000,000 shares, with the largest shareholder, Qu Jianguo, holding 55,159,552 shares, accounting for approximately 52.94% of the total[11]. - Qu Jianguo's shareholding decreased from 220,638,209 shares to 194,638,209 shares after donating 26,000,000 shares to the Shanghai Jianguo Social Public Welfare Foundation, reducing his ownership percentage from 38.90% to 34.32%[15]. - The Shanghai Jianguo Social Public Welfare Foundation's shareholding increased from 6,896,593 shares to 32,896,593 shares, representing an increase from 1.22% to 5.80% of the total shares[15]. - The company has a total of 166,042,328 restricted shares, with no shares released or added during the reporting period[13]. - Highsen Investment reduced its holdings from 28,343,455 shares to 2,759,3455 shares, representing a decrease of approximately 4.8651% of the total shares during its reduction plan[15]. Operational Highlights - The weighted average return on equity was 1.32%, down from 2.15% in the same period last year, reflecting a decrease of 0.83%[3]. - Financial expenses decreased by 32.07% to CNY 3,320,288.95, primarily due to increased foreign exchange gains compared to the previous year[7]. - Other income decreased by 75.31% to CNY 930,048.18, as there were no similar pandemic subsidies received in the current period[7]. - The company’s inventory increased to CNY 326,269,056.74 from CNY 292,682,613.72, marking a rise of about 11.5%[23][24]. - The company’s accounts receivable slightly decreased to CNY 232,421,351.20 from CNY 236,163,370.79, a decline of approximately 1.6%[23]. - The company’s long-term equity investments decreased to CNY 41,529,104.43 from CNY 42,411,800.06, a decline of approximately 2.1%[24]. - The company’s retained earnings increased to CNY 389,900,569.68 from CNY 373,976,278.48, reflecting an increase of about 4.3%[25]. - Research and development expenses rose to $13.26 million, compared to $10.92 million in the previous period, indicating an increase of about 21.43%[28]. Future Outlook and Developments - The company plans to terminate the non-public issuance of A-shares due to changes in external conditions and comprehensive considerations of its actual situation and development plans[15]. - The company has not disclosed any new product or technology developments in this report[15]. - There are no updates on market expansion or mergers and acquisitions mentioned in the report[15]. - The company has not provided specific future performance guidance or outlook in this report[15].

Financial Performance - The company's operating revenue for 2021 was ¥1,511,487,428.56, representing a 27.97% increase compared to ¥1,181,121,636.37 in 2020[23]. - Net profit attributable to shareholders for 2021 reached ¥104,859,883.20, a significant increase of 296.93% from ¥26,417,590.62 in 2020[23]. - The net profit after deducting non-recurring gains and losses was ¥63,339,903.42, up 6,930.19% from ¥900,970.21 in 2020[23]. - The total assets of the company at the end of 2021 were ¥2,132,858,918.73, an increase of 17.29% from ¥1,818,405,772.85 at the end of 2020[23]. - The company reported a basic earnings per share of ¥0.18 for 2021, a 260.00% increase from ¥0.05 in 2020[23]. - The company achieved a weighted average return on equity of 8.90% in 2021, up from 2.22% in 2020[23]. - The company reported a total revenue of 221,519,241 in the fiscal year 2021, with a significant increase compared to the previous year[145]. - The company reported a total revenue of 419.29 million for the year 2021[161]. Dividend Distribution - The company plans to distribute a cash dividend of 1.00 RMB per 10 shares to all shareholders, based on a total of 567,171,929 shares[9]. - The total cash dividend distributed to shareholders was RMB 28,467,257.45, with a payout of RMB 0.50 per 10 shares[180]. - A three-year dividend return plan (2021-2023) was approved, reflecting the company's commitment to shareholder returns[161]. - The total distributable profit for the company was RMB 266,221,910.19, with cash dividends accounting for 100% of the profit distribution[182]. Market Expansion and Strategy - The company is actively expanding its overseas sales channels while maintaining its market share in Europe and the US[5]. - The company anticipates a rebound in consumer demand following the easing of COVID-19 restrictions, supported by government measures to stimulate investment and consumption[9]. - The company is focused on enhancing the operational performance of its acquired subsidiaries to achieve synergies and mutual benefits[8]. - The company is taking measures to mitigate the impact of the pandemic on its operations, anticipating a rebound in consumer demand as restrictions ease[132]. - The company aims to establish a digital information system, including a PLM system, to improve the integration of R&D, production, and sales information[126]. - The company will continue to expand its overseas market presence by focusing on channel penetration and developing a proactive marketing model[127]. Research and Development - The company is actively involved in the development of water treatment products, focusing on improving water quality for residential use, and has received various national certifications[33]. - The company invested CNY 54,586,083.02 in R&D in 2021, representing 3.61% of its operating revenue, a slight increase from 3.56% in 2020[78]. - The number of R&D personnel increased by 15.83% to 139 in 2021, with a notable rise in the proportion of employees aged over 40, which increased by 33.33%[78]. - The company completed several new product developments in 2021, including a wall-mounted soft water machine and a highly integrated under-sink soft water machine with IoT capabilities[77]. - The company plans to enhance its R&D investment in 2022, focusing on new product development and increasing the sales proportion of new products[125]. - The company is actively investing in research and development to innovate and improve its product line[151]. Acquisitions and Mergers - The company has engaged in strategic mergers and acquisitions to gain new businesses and markets, which may increase financial pressure and require enhanced financial management[8]. - The company acknowledges the financial risks associated with mergers and acquisitions, particularly regarding goodwill impairment if performance does not meet expectations[8]. - The company completed the acquisition of Zhejiang Runxin, holding a 55% stake, with an investment of CNY 66,055,000.00[97]. - The acquisition of a 55% stake in Runxin Electric has added goodwill of approximately 9.19 million CNY to the company's balance sheet, but it also poses potential financial risks if the acquired entity does not perform as expected[132]. Operational Efficiency and Cost Management - The company emphasizes improving production efficiency and reducing costs to mitigate the impact of foreign exchange fluctuations[6]. - The company is focusing on enhancing production efficiency and cost management to mitigate risks associated with rising operating costs due to increasing labor and material prices[131]. - The company has a production capacity of over 90% for its core components and products, ensuring high-quality manufacturing[48]. Corporate Governance - The company maintained independence from its controlling shareholder in terms of business, personnel, assets, and finance, ensuring autonomous operations[142]. - The company emphasized transparency in information disclosure, with the chairman as the primary responsible person for information disclosure[140]. - The company has established a performance evaluation and incentive mechanism for senior management, promoting accountability and transparency[140]. - The company has not experienced any significant deviations from the governance standards set by regulatory authorities[141]. - The company actively engages with investors through multiple communication channels, enhancing investor relations management[140]. Environmental Responsibility - The company has established a comprehensive environmental management system and has not experienced any environmental pollution incidents[198]. - Measures have been implemented to reduce carbon emissions, including a wastewater treatment system that meets national standards[198]. - The company has reduced wastewater discharge by 560,000 tons from 2013 to 2021 through a full water reuse negative emission system[199]. - The company invested over 1 million yuan in the renovation of 63 natural rivers, transforming polluted rivers into clean rivers[200]. - The company has built a 1 MW photovoltaic power station, generating over 1 million kWh of electricity annually, contributing to reduced carbon emissions[200]. Employee Management and Development - The total number of employees at the end of the reporting period is 1,508, with 590 in the parent company and 918 in major subsidiaries[169]. - The company has established a comprehensive salary management and assessment system in accordance with national labor laws and regulations[170]. - The company has implemented a long-term incentive policy to stabilize key employees and attract high-quality talent[172]. - The company has conducted training programs to enhance core competencies among management and employees, focusing on key business scenarios[175]. - The company has established a talent development plan, including a project for key position talent cultivation involving over 60 core and management personnel[174].

Financial Performance - The company's revenue for Q3 2021 was CNY 410,086,351.33, representing a year-on-year increase of 15.95% and a year-to-date increase of 31.44% to CNY 1,105,083,748.49[3] - The net profit attributable to shareholders for Q3 2021 was CNY 28,247,273.29, a decrease of 29.33% compared to the same period last year, while the year-to-date net profit increased by 20.84% to CNY 85,076,950.55[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2021 was CNY 21,580,786.31, down 43.35% year-on-year, with a year-to-date figure of CNY 74,208,007.44, up 12.80%[3] - The company reported a basic earnings per share of CNY 0.05 for Q3 2021, down 28.57% year-on-year, while the diluted earnings per share remained the same[3] - Total operating revenue for Q3 2021 reached ¥1,105,083,748.49, an increase of 31.5% compared to ¥840,756,944.40 in Q3 2020[29] - Net profit for Q3 2021 was ¥99,969,154.95, representing a 13.9% increase from ¥87,857,281.99 in Q3 2020[30] - The net profit attributable to the parent company for Q3 2021 was ¥85,076,950.55, an increase from ¥70,404,264.73 in the same period last year, representing a growth of approximately 20.5%[31] - The total comprehensive income attributable to the parent company for Q3 2021 was ¥84,470,927.12, compared to ¥67,601,395.45 in Q3 2020, reflecting an increase of about 25%[31] Assets and Liabilities - The company's total assets as of September 30, 2021, were CNY 2,048,755,887.53, an increase of 12.67% compared to the end of the previous year[3] - Total assets amounted to CNY 1,818,405,772.85, a decrease of CNY 46,335,027.10 compared to the previous period[37] - Total liabilities increased to ¥804,796,654.23 from ¥601,901,272.25, a rise of 33.7%[27] - The company's total liabilities increased significantly, with long-term borrowings rising by 52.92% to CNY 8,380,000.00 from CNY 5,480,000.00, attributed to new loans taken by subsidiaries[8] - Total liabilities reached CNY 601,901,272.25, a decrease of CNY 46,335,027.10 from the previous period[38] - Current liabilities totaled CNY 489,929,439.25, showing a decrease of CNY 8,991,349.06[38] Cash Flow - The company's cash flow from operating activities for the year-to-date period was CNY 124,545,897.38, reflecting a significant increase of 68.66%[3] - The net cash flow from operating activities increased by 68.66% to CNY 124,545,897.38, up from CNY 73,843,578.16, driven by higher sales collections[8] - The net cash flow from operating activities for Q3 2021 was ¥124,545,897.38, up from ¥73,843,578.16 in Q3 2020, indicating a year-over-year increase of approximately 68.7%[33] - The net cash flow from investing activities was negative at -¥92,964,254.00 for Q3 2021, a decrease from a positive cash flow of ¥47,348,116.59 in Q3 2020[34] - The cash flow from investment activities decreased by 86.95% to CNY 55,404,902.45, down from CNY 424,568,895.95, due to reduced idle funds available for investment[8] Inventory and Receivables - The company's inventory increased by 34.10% to CNY 272,814,926.41, attributed to sales growth and preparations for Q4 sales[7] - The company's accounts receivable rose by 32.31% to CNY 230,409,831.10, driven by increased sales during the period[7] - Accounts receivable increased to ¥230,409,831.10, up 32.3% from ¥174,139,954.53[25] - Inventory rose to ¥272,814,926.41, an increase of 34.1% compared to ¥203,440,769.75[25] Expenses - Operating costs increased by 39.45% to CNY 645,126,454.28, up from CNY 462,605,565.31, primarily due to the significant rise in sales revenue[8] - Research and development expenses rose by 63.84% to CNY 35,245,649.30, compared to CNY 21,512,359.87, reflecting the company's commitment to new product development[8] - The company reported R&D expenses of ¥35,245,649.30, which is a 63.9% increase from ¥21,512,359.87 in the previous year[30] Shareholder Information - The company approved a share repurchase plan with a budget of between 20 million and 30 million RMB, with a maximum repurchase price of 7.45 RMB per share, and completed the repurchase of 4,215,800 shares by June 30, 2021[14] - The company plans to issue A-shares at a price of 4.63 RMB per share, raising between 100 million and 150 million RMB, with a minimum issuance of 21,367,522 shares[18] - As of October 12, 2021, the major shareholder Gaosen Investment reduced its holdings by 5,245,118 shares, bringing its total ownership to 4.99998%[23] - The company reported a total of 166,237,720 shares subject to lock-up at the end of the reporting period, with specific release schedules for executives[13] Future Plans - The company plans to continue expanding its market presence and investing in new technologies to support future growth[8] - The company has implemented new leasing standards starting from 2021, with no retrospective adjustments made[39]

Financial Performance - The company's operating revenue for the first half of 2021 was ¥694,997,397.16, representing a 42.68% increase compared to ¥487,091,601.13 in the same period last year[22]. - The net profit attributable to shareholders of the listed company reached ¥56,829,677.26, an increase of 86.74% from ¥30,432,176.92 in the previous year[22]. - The net cash flow from operating activities was ¥78,073,653.46, showing a significant increase of 361.29% compared to ¥16,925,155.98 in the same period last year[22]. - Basic earnings per share doubled to ¥0.10 from ¥0.05 in the previous year, indicating a 100% increase[22]. - The company's operating revenue for the current period reached approximately ¥694.99 million, representing a year-on-year increase of 42.68% compared to ¥487.09 million in the same period last year[48]. - The net profit attributable to shareholders, excluding non-recurring gains and losses, increased by 90.05% to approximately ¥52.63 million from ¥27.69 million in the previous year[48]. - The company's total profit for the first half of 2021 was CNY 43,664,942.81, an increase from CNY 31,250,189.58 in the first half of 2020, representing a growth of approximately 40%[171]. - The company's net profit for the first half of 2021 reached CNY 37,263,314.12, an increase from CNY 30,661,711.57 in the same period of 2020, representing a growth of approximately 21%[171]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,985,958,172.76, a 9.21% increase from ¥1,818,405,772.85 at the end of the previous year[22]. - The total liabilities as of the end of the reporting period were ¥501,030,812.55, an increase of 18.9% from ¥421,621,482.27 at the end of the previous year[166]. - Cash and cash equivalents at the end of the reporting period amounted to approximately 189.99 million, representing 9.57% of total assets, a decrease of 0.19% from the previous year[56]. - The total equity attributable to shareholders decreased to CNY 1,163,098,090.10 from CNY 1,172,657,499.93, a decline of approximately 0.80%[159]. - The company's total assets reached CNY 1,985,958,172.76, compared to CNY 1,818,405,772.85 at the end of 2020, showing an increase of about 9.19%[159]. Cash Flow - The net cash flow from financing activities increased by 132.43% to approximately ¥17.98 million, primarily due to a net inflow from bank borrowings[48]. - The net cash flow from operating activities surged by 361.29% to approximately ¥78.07 million, up from ¥16.93 million, driven by substantial growth in sales collections[48]. - The net cash flow from investment activities was negative at -¥50,713,716.37, contrasting with a positive cash flow of ¥26,436,214.84 in the previous year, representing a significant shift in investment performance[179]. Market and Product Development - The company reported a significant increase in revenue due to the recovery of downstream markets and the launch of new products, leading to a substantial rise in net profit compared to the same period last year[41]. - The company has established a comprehensive range of water treatment products, covering 8 major categories, 83 series, and over 1,700 specifications, with exports to more than 100 countries and regions[30]. - The company emphasizes innovation and maintains a leading position in technology development and product design, particularly in integrated applications of whole-house water treatment equipment[46]. - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[157]. Research and Development - Research and development expenses slightly decreased by 1.98% to approximately ¥21.83 million from ¥22.27 million in the previous year[48]. - The company has allocated resources for research and development, focusing on innovative health solutions to meet growing consumer demand[184]. Shareholder and Equity Information - The company plans not to distribute cash dividends or issue bonus shares for this period[6]. - The company did not distribute any dividends during the reporting period, retaining all profits for reinvestment[189]. - The company’s total equity at the end of the reporting period was RMB 1,106,658,600, showing an increase from the previous period[192]. Risks and Challenges - The company has faced risks due to global pandemic impacts, but anticipates a rebound in consumer demand as the situation improves[85]. - Rising operating costs due to increased labor and material prices pose a risk, prompting the company to improve production efficiency[87]. - The company has identified a talent shortage as a risk, emphasizing the need for specialized R&D and management personnel[87]. Corporate Governance - The company has established measures to ensure that any necessary related transactions are conducted in compliance with legal regulations and fair commercial practices[105]. - The company confirmed that there were no violations of the commitment regarding the relinquishment of voting rights on 40,881,600 shares of Kaineng Health[104]. - The company did not undergo an audit for the semi-annual financial report[108]. Miscellaneous - The company has not disclosed any significant new product developments or market expansion strategies in this report[29]. - The company has not reported any significant new product launches or technological advancements in this period[189].

Financial Performance - The company's operating revenue for 2020 was CNY 1,181,121,636.37, representing a 12.22% increase compared to CNY 1,052,525,499.43 in 2019[21] - The net profit attributable to shareholders decreased by 73.72% to CNY 26,417,590.62 from CNY 100,512,740.94 in the previous year[21] - The net profit after deducting non-recurring gains and losses was CNY 900,970.21, down 98.89% from CNY 81,416,926.98 in 2019[21] - The net cash flow from operating activities increased by 22.76% to CNY 140,429,986.48 from CNY 114,397,474.13 in 2019[21] - The total assets at the end of 2020 were CNY 1,818,405,772.85, a decrease of 7.82% from CNY 1,972,725,832.32 at the end of 2019[21] - The net assets attributable to shareholders decreased by 1.90% to CNY 1,172,657,499.93 from CNY 1,195,429,057.93 in 2019[21] - The basic earnings per share dropped by 70.59% to CNY 0.05 from CNY 0.17 in the previous year[21] - The weighted average return on net assets was 2.22%, down 6.27% from 8.49% in 2019[21] Market Expansion and Strategy - The company plans to expand overseas sales channels while maintaining its market share in Europe and the United States[5] - The company is actively pursuing mergers and acquisitions to enhance its business and market presence, which may increase financial pressure and require improved risk management[8] - The company aims to leverage the trend of consumption upgrading in China to expand its market presence and enhance service offerings[40] - The company’s marketing strategy includes targeting both domestic and international markets, focusing on customized solutions for various customer needs[32] - The company has actively pursued a "go global" strategy, offering competitive pricing and high-quality products to international markets[48] Product and Innovation - The company has established a strong brand presence in over 100 countries, focusing on comprehensive water treatment solutions[30] - The company has been recognized as a national high-tech enterprise since 2008, enhancing its credibility in the water treatment industry[39] - The company’s products have received multiple international certifications, including NSF and CE, indicating compliance with global safety and environmental standards[38] - The company has a diverse product range, including over 1,700 specifications across 83 series, catering to residential, commercial, and public facility water treatment needs[30] - The company launched several new products, including a customized non-electric softener for the UK market, enhancing its competitive edge[59] - The company holds a total of 196 authorized patents, including 22 invention patents, reflecting its commitment to innovation and technology leadership[50] Financial Management and Investments - Long-term equity investments decreased by approximately 55.96 million, a decline of 53.81%, due to impairment provisions based on asset evaluations of a joint venture[42] - Trading financial assets decreased by approximately 40.03 million, a decline of 99.60%, as the company recovered investments to maintain liquidity[42] - The company reported a long-term equity investment impairment provision of approximately 55 million yuan due to the valuation of its 40% stake in Zhejiang Runxin Electric Co., Ltd.[54] - The gross profit margin for product sales remained at a high level, indicating continued strong profitability in core operations[55] - The total R&D investment for 2020 was ¥42,029,966.43, representing 3.56% of total revenue[84] Operational Efficiency - The company has achieved over 90% vertical integration in its production capabilities, enhancing product quality and manufacturing efficiency[46] - The digital factory project aims to improve operational efficiency and product quality through automation and data-driven management[63] - The company aims to enhance production efficiency and reduce costs to mitigate the risk of rising operating costs due to increasing labor and material prices[130] - The company plans to optimize its organizational structure and management processes to improve operational efficiency and profitability in 2021[125] Corporate Governance and Shareholder Relations - The company has committed to avoiding competition with its subsidiary, ensuring the interests of minority shareholders are protected[147] - The company has established a stock incentive plan without providing financial assistance or guarantees to the incentive targets[151] - The company has reiterated its commitment to uphold all promises made regarding shareholding and related transactions, with no reported violations[151] - The company plans to submit the 2020 profit distribution proposal for approval at the annual shareholders' meeting[144] Social Responsibility - The company donated nearly 400 business water dispensers to hospitals in response to the COVID-19 pandemic[64] - The company was recognized for its contributions during the pandemic, receiving the "Outstanding Contribution Award" from the Environmental Services Industry Association[67] Challenges and Risks - The company has identified a risk of talent shortages that could hinder business development and plans to optimize team structure and attract new talent[130] - The company has implemented measures to counteract the negative impacts of the pandemic, with expectations of a rebound in consumer demand as the situation improves[131]

Financial Performance - The company's revenue for Q1 2021 was CNY 328,165,726.15, representing a 63.33% increase compared to CNY 200,922,590.35 in the same period last year[7]. - Net profit attributable to shareholders reached CNY 25,325,231.55, a significant increase of 2,816.89% from CNY 868,225.96 year-on-year[7]. - The net profit after deducting non-recurring gains and losses was CNY 22,582,688.74, up 1,215.06% from CNY 1,717,238.15 in the previous year[7]. - Basic earnings per share were CNY 0.0443, reflecting a 2,853.33% increase from CNY 0.0015 in the previous year[7]. - The company achieved total revenue of 328.17 million yuan in Q1 2021, a year-on-year increase of 63.33%[18]. - Net profit attributable to shareholders reached 25.33 million yuan, a significant increase of 2,816.89% compared to the same period last year[18]. - The net profit excluding non-recurring gains and losses was 22.58 million yuan, up 1,215.06% year-on-year, driven by improved management efficiency and cost control[18]. - The company reported a total comprehensive income of CNY 30,982,967.44 for Q1 2021, compared to CNY 4,612,070.79 in Q1 2020, marking an increase of approximately 572.5%[56]. - The total profit before tax for Q1 2021 was CNY 35,320,440.28, a substantial increase from CNY 3,045,541.15 in Q1 2020, reflecting a growth of approximately 1,058.5%[56]. Cash Flow - The net cash flow from operating activities was CNY 28,443,512.37, a 415.60% increase compared to a negative cash flow of CNY 9,012,489.60 in the same period last year[7]. - The cash flow from operating activities was CNY 321,554,549.70, compared to CNY 219,576,898.68 in the previous period, indicating a strong cash generation capability[61]. - Total cash inflow from operating activities reached ¥334,404,177.61, up from ¥227,632,515.73 in the previous year, indicating a growth of approximately 47%[63]. - The net cash flow from operating activities for Q1 2021 was ¥28,443,512.37, a significant improvement compared to a net outflow of ¥9,012,489.60 in Q1 2020, representing a turnaround of over 415%[63]. - The ending balance of cash and cash equivalents was ¥149,401,348.09, compared to ¥103,419,002.60 at the end of Q1 2020, marking an increase of approximately 44.5%[64]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,905,681,616.35, a 4.80% increase from CNY 1,818,405,772.85 at the end of the previous year[7]. - The company's current assets totaled CNY 690,102,722.70, slightly up from CNY 679,287,439.15 at the end of 2020, indicating a growth of about 2.4%[45]. - The total liabilities increased to CNY 690,102,722.70, up from CNY 679,287,439.15, reflecting a growth of about 1.2%[45]. - The total liabilities as of March 31, 2021, were CNY 679,775,173.60, compared to CNY 601,901,272.25 at the end of 2020, showing an increase in financial obligations[48]. - Total equity reached CNY 1,216,504,500.60, remaining stable compared to the previous reporting period[70]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 18,841[11]. - The largest shareholder, Qu Jianguo, holds 38.25% of the shares, totaling 220,638,209 shares[11]. - Kaineng Health's shareholding in Yuaneng Group increased from 15.1% to 19.98% following a capital reduction by Yuaneng Group[32]. Research and Development - R&D expenses increased by 87.63% to approximately 5.10 million yuan, reflecting the company's commitment to new product development[22]. - Research and development expenses for the quarter were CNY 6,192,400.52, up from CNY 3,709,000.16 in the previous year, reflecting a 67.0% increase[58]. Strategic Initiatives - The company plans to continue expanding its overseas market presence and launching new products to capitalize on the recovery in consumer demand[27]. - The company is committed to using repurchased shares for employee stock ownership plans or equity incentives[32]. - The company maintains a focus on strategic investments and partnerships to enhance its market position and operational capabilities[32]. Share Buyback Plans - The company initiated a share buyback plan with a budget of up to 30 million RMB, with a minimum of 15 million RMB, to repurchase A-shares at a price not exceeding 7.00 RMB per share[32]. - As of March 31, 2021, the total number of shares repurchased was 5,784,220, representing 1.003% of the company's total share capital[33]. - A second share buyback plan was approved with a budget of up to 30 million RMB, with a minimum of 20 million RMB, and a price cap of 7.50 RMB per share[33]. - The first buyback was executed between August 2020 and January 2021, with a total expenditure of approximately 29.99 million RMB[33]. Compliance and Governance - The company reported no violations regarding external guarantees during the reporting period[38]. - There were no non-operating fund occupations by controlling shareholders or their affiliates during the reporting period[39]. - The company did not engage in any research, communication, or interview activities during the reporting period[40].

Financial Performance - Operating revenue for the reporting period was CNY 353,665,343.27, an increase of 27.57% year-on-year[7] - Net profit attributable to shareholders was CNY 39,972,087.81, representing a growth of 41.82% compared to the same period last year[7] - The net cash flow from operating activities was CNY 56,918,422.18, an increase of 67.84% year-on-year[7] - Basic earnings per share for the reporting period were CNY 0.07, up 40.00% from the previous year[7] - The weighted average return on net assets was 3.27%, an increase of 0.87% compared to the previous year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 38,097,837.52, an increase of 37.77% year-on-year[7] - Total operating revenue for Q3 2020 was CNY 353,665,343.27, an increase of 27.5% compared to CNY 277,239,343.48 in the same period last year[46] - Net profit for Q3 2020 reached CNY 49,749,195.32, representing a 45.5% increase from CNY 34,267,945.55 in Q3 2019[48] - The company reported a total comprehensive income of CNY 47,983,376.14 for Q3 2020, compared to CNY 34,775,949.62 in the same period last year[49] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,877,346,180.09, a decrease of 4.83% compared to the end of the previous year[7] - Cash and cash equivalents decreased by approximately 65.43 million, a decline of 31.75%, primarily due to early repayment of various loans totaling over 70 million[18] - Current assets decreased from RMB 730,472,914.68 at the end of 2019 to RMB 652,756,117.06 as of September 30, 2020[38] - Total liabilities decreased from RMB 743,383,371.42 at the end of 2019 to RMB 617,910,004.97 as of September 30, 2020[40] - The company's equity attributable to shareholders increased from RMB 1,195,429,057.93 at the end of 2019 to RMB 1,218,901,885.73 as of September 30, 2020[41] - The company's total assets amounted to CNY 1,623,023,207.55, a slight decrease from CNY 1,719,732,178.27 at the end of the previous quarter[44] - Total liabilities decreased to CNY 507,211,147.13 from CNY 614,595,527.00 in the previous quarter[44] Shareholder Information - The company reported a total of 18,615 common shareholders at the end of the reporting period[11] - The largest shareholder, Qu Jianguo, holds 37.86% of the shares, totaling 220,638,209 shares[11] - The company’s total restricted shares at the end of the period were 178,308,242, with 28,829,034 shares released from restrictions during the period[15] - The company has been involved in legal proceedings affecting its major shareholder's stock holdings, leading to significant share reductions[23] - The company implemented a share repurchase plan with a budget of CNY 30 million to CNY 15 million, repurchasing shares at a maximum price of CNY 7.00 per share[25] - As of the report date, the company had repurchased a total of 1,865,400 shares, accounting for 0.320% of the total share capital, with an average repurchase price of CNY 5.68 per share[25] Research and Development - R&D expenses increased by approximately 9.28 million, a growth of 75.81%, driven by ongoing new product development and additional R&D expenditures[19] - Research and development expenses for Q3 2020 were CNY 9,292,459.56, significantly higher than CNY 4,823,030.13 in Q3 2019, indicating a focus on innovation[47] - Research and development expenses increased significantly to ¥13,209,451.83, up from ¥7,958,065.84, marking a rise of about 65.5%[59] Cash Flow - Net cash flow from investment activities decreased by approximately 301.30 million, a decline of 44.41%, due to reduced idle funds and corresponding investment amounts[21] - Net cash flow from financing activities increased by approximately 170.65 million, a rise of 76.17%, as the company repaid various loans to lower financing costs[21] - The net increase in cash and cash equivalents was approximately 15.86 million, an increase of 51.30%, attributed to improved operating cash flow[21] - Cash flow from operating activities generated a net amount of ¥73,843,578.16, compared to ¥67,108,228.13 in the previous period, indicating a growth of approximately 10.5%[61] - Cash inflow from investment activities totaled ¥424,568,895.95, down from ¥578,008,516.26, reflecting a decrease of about 26.5%[63] - The company reported a net cash outflow from financing activities of ¥134,934,867.10, compared to a smaller outflow of ¥3,486,440.35 in the previous period[63] Government Subsidies and Other Income - The company received government subsidies amounting to CNY 12,423,622.14 during the reporting period[9] - Other income increased by approximately 9.13 million, a surge of 277.26%, largely due to government subsidies received by the Canadian subsidiary[20] Legal and Compliance - The company has no overdue commitments from actual controllers, shareholders, or related parties during the reporting period[28] - There were no violations regarding external guarantees during the reporting period[32] - The company has not disclosed any performance forecasts for the upcoming reporting period[29] Dividend Distribution - The company distributed a cash dividend of RMB 0.5 per 10 shares, totaling RMB 29,139,745.45, with a remaining undistributed profit of RMB 242,148,875.77 for the next year[31] - The company reported a total of CNY 271,288,621.22 available for distribution to shareholders after accounting for reserves and previous distributions[30] - The company’s cash dividend policy was executed according to the articles of association, with a clear distribution plan approved by the shareholders' meeting[30]